FDA clearance

FDA Approves Foundation Medicine Blood Test as CDx for Rozlytrek

FDA Approves Thermo Fisher HLA Typing Test as CDx for Immunocore Uveal Melanoma Therapy

Sofie Biosciences to Begin Trial of Fluorine-Labeled PET Diagnostic Imaging Agent for GI Cancers

Legend Biotech to Launch CAR T-Cell Therapy Trial for Small Cell Lung Cancer, Neuroendocrine Tumors

FDA Approves ImmunoGen's Elahere for Folate Receptor Alpha-Positive Ovarian Cancer

Thermo Fisher Gets FDA OK for CDx Test to Guide Use of Lilly Drug in Lung, Thyroid Cancers

Monte Rosa to Begin Phase I/II Trial of MRT-2359 in MYC-Driven Solid Cancers

Verismo Therapeutics Files IND to Study Cell Therapy in Advanced Mesothelin-Expressing Solid Tumors

FDA Approves Enhertu for HER2-Low Metastatic Breast Cancer

MD Anderson, Obsidian Therapeutics to Launch First-In-Human Trial of Engineered TILs for Melanoma

Pfizer's Xalkori Gets FDA Approval for ALK-Positive Inflammatory Myofibroblastic Tumors

Angle Gets FDA Clearance for Breast Cancer Cell Isolation System

Lyell Immunopharma's IND for T-Cell Receptor Therapy Gets FDA Clearance

23andMe Gains FDA Clearance for Direct-to-Consumer Prostate Cancer Genetic Risk Test

FDA Clears Jubilant Therapeutics' IND Allowing for LSD1/HDAC6 Inhibitor Clinical Trial

Regor Therapeutics to Begin US CDK2/4/6 Inhibitor Study for HR-Positive, HER2-Negative Breast Cancer

Lyell Immunopharma Receives IND Clearance for Phase I Trial of CAR T-Cell Therapy for ROR1-Expressing TNBC, NSCLC

FDA Approves Thermo Fisher Scientific Oncomine Dx Assay as CDx for Janssen Lung Cancer Drug

Ikena Oncology to Launch Trial of TEAD Inhibitor in Biomarker-Selected Cancers

Precigen to Study Anti-ROR1 CAR T-Cell Therapy for TNBC, Hematologic Cancers